Antiarrhythmic Amiodarone Hydrochloride Raw Powder Amiodarone Hydrochloride Amiodarone HCl

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Amiodarone Hydrochloride
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Product Name: Amiodarone Hydrochloride
• Name: Amiodarone HCl
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antiarrhythmic
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 19774-82-4
• Mf: C25h30cli2no3
• MW: 681.778
• Density: 1.58
• Melting Point: 154-158°c
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 500kg/Month

Product Description

Antiarrhythmic Amiodarone Hydrochloride Raw Powder Amiodarone Hydrochloride Amiodarone Hcl

Product Description

Product Details

Product name	Amiodarone Hydrochloride
Cas number	19774-82-4
Apperance	White powder
MF	C25H30ClI2NO3
MW	681.778
Melting point	154-158°C
Density	1.58

Amiodarone is an antiarrhythmic drug for inhibition of ATP-sensitive potassium channel with IC50 of 19.1 μM. IC50 Value: 1.5 uM ( inhibit TBARS, LOOH and FPL formation)[1]in vitro: It was found that 10 uM amiodarone induces accumulation of ethidium bromide (5 ug/ml) in Saccharomyces cerevisiae cells. At the same time, in yeast cells with inactivated MDR genes, accumulation of ethidium bromide was 6-fold higher even without amiodarone. Addition of non-lethal concentrations of amiodarone to MDR-deficient cells caused an increase of intracellular ethidium bromide to the level, which was even lower than the level in amiodarone-treated wild-type cells [2]. Cells treated with amiodarone were seen to have detached from the dish, with cell rounding, cytoplasmic blebbing and irregularity in shape. An increase in the sub-G1 phase fraction, from 15.43 to 21.34% and 79.83% and a reduction in the G1 phase fraction, from 48.83 to 41.63% and 11.52%, were observed in cells treated with amiodarone at concentrations of 0.1 and 1 mM, respectively [3].in vivo: Chronic treatment with oral amiodarone for 4 weeks reduced i.p. when myocytes were dialyzed with patch-pipettes containing either 10 mM Na+ or 80 mM Na+. In myocytes from untreated rabbits, acute exposure to amiodarone in vitro reduced i.p. when patch pipettes contained 10 mM Na+ but had no effect on i.p. at 80 mM Na+. Amiodarone had no effect on the voltage dependence of the pump or the affinity of the pump for extracellular K+ either after chronic treatment or during acute exposure [4].Clinical trial: Continuous Versus Episodic Amiodarone Treatment for the Prevention of Permanent Atrial Fibrillation. 

Application&Function

Amiodarone hydrochloride can prevent some paroxysmal or ventricular tachycardia and ventricular fibrillation. It is also suitable for improving paroxysmal ventricular tachycardia when the drug effect is poor. It is also suitable for paroxysmal atrial flutter and atrial fibrillation.

Specification